We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New X-Ray Camera to Shed Light About How Chemistry Works

By LabMedica International staff writers
Posted on 16 Aug 2011
Designed to record bursts of images at an unprecedented speed of 4.5 million frames per second, an innovative X-ray camera will help a major new research facility provide details on the structure of matter.

The camera is being built with Science and Technology Facilities Council’s (STFC; Swindon, UK) world-class engineering expertise. More...
The unique device will be delivered to the billion-euro European XFEL (X-ray free-electron laser; (Hamburg, Germany) in 2012 and will contribute to drug discovery and other vital research once this facility starts operating in 2015. The go-ahead for continuation of the GBP 3 million prototype collaboration contract for the camera’s construction has been confirmed following a visit to STFC by a delegation from the European XFEL’s Detector Advisory Committee.

The decision to entrust construction of this crucial piece of equipment to STFC recognizes the organization's outstanding capabilities in advanced microelectronics and the design of high-tech imaging devices (e.g., for the large Hadron collider at CERN).

Now under construction near Hamburg in Northern Germany, the European XFEL is a two-mile-long facility that will use superconducting accelerator technology to accelerate electrons that then generate X-ray flashes a billion times brighter than those produced by traditional X-ray sources. Each flash will last less than one hundred million billionth of a second. With the properties of laser light, these short, intense flashes will, for example, make it possible to take three-dimensional X-ray images of single molecules.

Current leading-edge X-ray cameras are designed to capture images when matter is bombarded by a constant beam of X-rays. But the extreme brevity and intensity of the flashes produced by the European XFEL means such cameras will not be suitable for use at the new facility.

STFC’s new device, which is being built in collaboration with the University of Glasgow (Scotland, UK), is specifically designed to work in conjunction with hyper-short, hyper-brilliant X-ray flashes. It will be installed in one of the first experimental endstations incorporated in the European XFEL. The device will help ensure that the European XFEL provides a unique opportunity for science and industry to understand matter and its behavior, mapping the atomic details of viruses, for instance, or pinpointing the molecular composition of individual cells.

Dr. Tim Nicholls of STFC, stated, “We’re delighted that the European XFEL has turned to STFC to build this pioneering camera. It demonstrates how the UK can provide the high-tech excellence that world markets need, leading to scientific advances that make a real difference to people’s lives.”

Dr. Markus Kuster, group leader of European XFEL GmbH’s detector development, said, “The European XFEL will represent a major step forward in equipping Europe with a new generation of research infrastructure that can meet the requirements of the 21st century. STFC’s unique skills are creating an imaging device which will help this remarkable facility realize its vast potential.”

Related Links:
Science and Technology Facilities Council
European XFEL
University of Glasgow


New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Human Estradiol Assay
Human Estradiol CLIA Kit
New
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
Image: (A) Normal skin and (B) possible pathology in ALS skin (Photo courtesy of Biomolecules and Biomedicine (2025) DOI: 10.17305/bb.2025.12100)

Skin-Based Biomarkers to Enable Early Diagnosis of Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that damages motor neurons in the brain and spinal cord, causing muscle weakness, paralysis, and death within three to five... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.